Crossmark

FDA: Beschleunigung für Gantenerumab

Crossref DOI link: https://doi.org/10.1007/s15005-021-2155-6

Published Online: 2021-11-19

Published Print: 2021-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Facharztmagazine, Redaktion
License Information

Text and Data Mining valid from 2021-11-01

Version of Record valid from 2021-11-01
More Information

Article History

First Online: 19 November 2021

Free to read: This content has been made available to all.